Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00374842
Status:
COMPLETED
Last Update Posted:
2018-06-08
First Post:
2006-09-08
Brief Title:
Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline GSK Biologicals GSK1247446A Low Dose Influenza Vaccine Candidate
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10-03
Start Date Type:
None
Primary Completion Date:
2006-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-11-30
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-08
First Submit QC Date:
September 8 2006
Study First Post Date:
2006-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2013-04-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-09
Last Update Post Date:
2018-06-08
Last Update Post Date Type:
ACTUAL